You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -9.9 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 8.2 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | n/a | -1.45 | -3.98p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2017-12-31 | n/a | -3.21 | -8.37p | -17.0 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
Destiny Pharma meets recruitment deadline for XF-73 trial Sharecast News | 05 Jan |
---|---|
Second Covid wave slows patient recruitment for Destiny Pharma Sharecast News | 12 Oct |
Destiny Pharma enters collaboration deal with SporeGen Sharecast News | 07 Sep |
Second Price Monitoring Extn | 10-Feb-21 14:08 |
---|---|
Price Monitoring Extension | 10-Feb-21 14:02 |
Brazilian Patent Granted for XF-73 nasal gel | 03-Feb-21 07:00 |
Destiny Pharma to join panel discussion at LSX | 02-Feb-21 09:31 |
Destiny Pharma Appoints Professor Mark Wilcox | 02-Feb-21 09:31 |